mechanism of action for tirzepatide Tirzepatide: A Promising Drug Type 2 Diabetes and Beyond Shifting the Scales: Tirzepatide's Breakthrough

Metformin is an oral prescription medication belonging to the biguanide class

Cardiovascular outcomes trials have demonstrated benefits, with semaglutide 2.4 mg now FDA-approved to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either overweight or obesity, based on the SELECT trial

KPV provides direct NF-kB suppression and cytokine reduction, while thymosin alpha-1 enhances the regulatory T cell function that should be preventing the autoimmune response in the first place

Statistical Analysis The data are expressed as the mean standard error of the mean (SEM)